School of Pharmacy, Bengbu Medical University, Bengbu, China.
Department of Critical Care Medicine, The First Hospital of Harbin, No 151, Diduan Street, Daoli District, Harbin, China.
Biomed Pharmacother. 2024 Jul;176:116844. doi: 10.1016/j.biopha.2024.116844. Epub 2024 May 31.
In contemporary times, tumors have emerged as the primary cause of mortality in the global population. Ongoing research has shed light on the significance of neurotransmitters in the regulation of tumors. It has been established that neurotransmitters play a pivotal role in tumor cell angiogenesis by triggering the transformation of stromal cells into tumor cells, modulating receptors on tumor stem cells, and even inducing immunosuppression. These actions ultimately foster the proliferation and metastasis of tumor cells. Several major neurotransmitters have been found to exert modulatory effects on tumor cells, including the ability to restrict emergency hematopoiesis and bind to receptors on the postsynaptic membrane, thereby inhibiting malignant progression. The abnormal secretion of neurotransmitters is closely associated with tumor progression, suggesting that focusing on neurotransmitters may yield unexpected breakthroughs in tumor therapy. This article presents an analysis and outlook on the potential of targeting neurotransmitters in tumor therapy.
在当代,肿瘤已经成为全球人口死亡的主要原因。正在进行的研究揭示了神经递质在肿瘤调节中的重要性。已经确定,神经递质通过触发基质细胞向肿瘤细胞的转化、调节肿瘤干细胞上的受体,甚至诱导免疫抑制,在肿瘤细胞血管生成中发挥关键作用。这些作用最终促进了肿瘤细胞的增殖和转移。已经发现几种主要的神经递质对肿瘤细胞具有调节作用,包括限制应急造血和与突触后膜受体结合的能力,从而抑制恶性进展。神经递质的异常分泌与肿瘤进展密切相关,这表明关注神经递质可能在肿瘤治疗方面取得意想不到的突破。本文对神经递质在肿瘤治疗中的靶向作用进行了分析和展望。